Otrivin Menthol (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. It binds to alpha‑adrenergic receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This narrows the vessels, decreases mucosal edema, and opens the nasal airway, providing rapid decongestion.

The appropriate dose of Otrivin Menthol is determined by a qualified prescriber or according to the product label. Typically, one or two sprays per nostril are used, not exceeding the recommended maximum daily frequency, and the treatment duration should not exceed 3‑5 days.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Otrivin Menthol to weigh potential benefits against any unknown risks.

To order Otrivin Menthol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Otrivin Menthol contains Xylometazoline, an alpha‑adrenergic agonist, which provides rapid vasoconstriction similar to other topical decongestants such as oxymetazoline. Compared with oral decongestants, it acts locally with fewer systemic effects, but all topical agents share the risk of rebound congestion if used beyond the recommended duration.

Store Otrivin Menthol at room temperature, below 25 °C, in its original packaging. Protect the spray from moisture, direct sunlight, and extreme heat. Keep the container tightly closed when not in use to maintain product integrity.

Otrivin Menthol is administered as a nasal spray. The user gently inserts the nozzle into one nostril, tilts the head slightly forward, and delivers the prescribed number of sprays. The same procedure is repeated for the other nostril if required, following the dosage instructions on the label.

Serious risks include severe hypertension, cardiac arrhythmias, nasal septum perforation from prolonged use, and rare anaphylactic reactions. Users should discontinue the spray and seek immediate medical attention if they experience symptoms such as a rapid rise in blood pressure, chest pain, severe nosebleeds, or signs of an allergic reaction.

Otrivin Menthol should not be used by children under 2 years of age, individuals with known hypersensitivity to Xylometazoline or any formulation component, and patients with severe hypertension or uncontrolled cardiovascular disease unless advised by a physician.